Everybody loves a villain and when it comes to 1923, no one is better at it than French-American actor Sebastian Roché. In ...

Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ...

Whether it’s a budget, a new hire or a family vacation, George A. Roche, the newly elected chairman and president of T. Rowe Price Associates Inc., isn’t satisfied until he has painstakingly ...

Roche, which put billions on the line a year ago across several ADC pacts, kicked off 2025 by returning to Innovent Biologics ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for GLP-1 weight-loss drugs. Current runners-up Viking Therapeutics ( VKTX 2.08 ...

ZURICH (Reuters) -Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker seeks to boost its prospects ...

The inquiry is the latest effort by the European Commission and European countries to scrutinize potential antitrust behavior ...

Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise Research Campus in Allston that could employ hundreds. The Roche ...

Roche Holding AG scrapped long-held global diversity targets for its leadership, showing how pressure from the Trump ...